Cardiovascular medication use in patients with undiagnosed obstructive sleep apnoea

Thorax

Volumn 57, Issue 5, 2002, Pages 417-422

  Otake, K ^a   Delaive, K ^a   Kryger, M H ^a   Walld, R ^b   Manfreda, J ^c  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b Centre for Health Policy and Evaluation   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMILORIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LABETALOL; LEVODOPA; LOOP DIURETIC AGENT; METHYLDOPA; METOLAZONE; METOPROLOL; MINOXIDIL; NADOLOL; PINDOLOL; PRAZOSIN; PROPRANOLOL; SOTALOL; SPIRONOLACTONE; TERAZOSIN; TRIAMTERENE; UNINDEXED DRUG;

ADULT; ANGINA PECTORIS; ARTICLE; BODY MASS; CANADA; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

BODY MASS INDEX; CARDIOVASCULAR AGENTS; DRUG COSTS; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES;

EID: 0036260873     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.5.417     Document Type: Article

References (28)

1. Obstructive sleep apnea
2. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients
3. Why should sleep apnea be diagnosed and treated?
4. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea
5. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea
6. Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea
7. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea
8. Hypertension in dogs with apnea
9. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study
10. Prospective study of the association between sleep-disordered breathing and hypertension
11. Prevalence of ischemic heart disease among patients with sleep apnea syndrome
12. Sleep-related breathing disorders and cardiovascular disease
13. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients
14. The occurrence of sleep-disordered breathing among middle-aged adults
15. Utilization of health care services in patients with severe obstructive sleep apnea
16. The population's use of pharmaceuticals
17. Health and health care: Experience with a population-based health information system
18. Daytime sleepiness, snoring, and obstructive sleep apnea: The Epworth sleepiness scale
19. Probable inference, the law of succession, and statistical inference
20. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated
21. What are obstructive sleep apnea patients being treated for prior to OSAS diagnosis?
22. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome
23. Continuous positive airways pressure for obstructive sleep apnoea
24. Identifying depression as a symptom of sleep apnea
25. The behavioral morbidity of obstructive sleep apnea